![]() | Up a level |
Condoluci, Adalgisa, di Bergamo, Lodovico Terzi, Langerbeins, Petra, Hoechstetter, Manuela A., Herling, Carmen D., De Paoli, Lorenzo, Delgado, Julio, Rabe, Kari G., Gentile, Massimo ORCID: 0000-0002-5256-0726, Doubek, Michael, Mauro, Francesca R., Chiodin, Giorgia, Mattsson, Mattias
ORCID: 0000-0002-9510-8801, Bahlo, Jasmin, Cutrona, Giovanna
ORCID: 0000-0002-3335-1101, Kotaskova, Jana, Deambrogi, Clara, Smedby, Karin E., Spina, Valeria, Bruscaggin, Alessio, Wu, Wei, Moia, Riccardo, Bianchi, Elena, Gerber, Bernhard, Zucca, Emanuele, Gillessen, Silke
ORCID: 0000-0001-5746-6555, Ghielmini, Michele, Cavalli, Franco, Stussi, Georg, Hess, Mark A., Baumann, Tycho S., Neri, Antonino, Ferrarini, Manlio, Rosenquist, Richard, Forconi, Francesco, Foa, Robin, Pospisilova, Sarka, Morabito, Fortunato, Stilgenbauer, Stephan, Doehner, Hartmut, Parikh, Sameer A., Wierda, William G., Montserrat, Emili, Gaidano, Gianluca, Hallek, Michael and Rossi, Davide
(2020).
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.
Blood, 135 (21).
S. 1859 - 1870.
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020
Mato, Anthony R., Yazdy, Maryam Sarraf, Hill, Brian T., Shadman, Mazyar, Tuncer, Hande, Winter, Allison M., Kennard, Kaitlin, Allan, John N., Ujjani, Chaitra S., Brander, Danielle M., Nabhan, Chadi, Barr, Paul ORCID: 0000-0002-9733-401X, Brown, Jennifer R., Fox, Christopher P., Rhodes, Joanna, Schuh, Anna, Eyre, Toby A., Lamanna, Nicole, Jain, Nitin, Wierda, William G., Skarbnik, Alan P., Roeker, Lindsey E., Bannerji, Rajat, Evens, Andrew M., Lansigan, Frederick, Samp, Jennifer C., Nielsen, Jacqueline, Pauff, James M., Kipps, Thomas J., Schuster, Stephen J., Follows, George A., Cheson, Bruce and Eichhorst, Barbara
(2018).
Treatment Patterns and Outcomes of Patients with CLL Treated with Chemoimmuno- and Novel Agent-Based Therapy: A Multicenter Study.
Blood, 132.
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020
Rawstron, Andy, Fazi, Claudia, Villamor, Neus, Delgado, Julio ORCID: 0000-0002-5157-4376, Letestu, Remi, Cymbalista, Florence, Palacio, Carlos, Bosch, Francesc
ORCID: 0000-0001-9241-2886, De Tute, Ruth M., Liptrot, Stuart, O'Brien, David, Spacek, Martin
ORCID: 0000-0001-5250-8218, Dobber, Johan, Kater, Arnon P., Gambell, Peter C., Westerman, David A., Soosapilla, Asha, Mulligan, Stephen P., Lozanski, Gerard, Lin, Ke, Pettitt, Andrew R., Brachtl, Gabi, Egle, Alexander, Williamson, David W., Sanders, Catherine M., Robins, Harlan, Boysen, Justin, Shanafelt, Tait D., Hanson, Curtis A., Jorgensen, Jeffrey L., Wierda, William G., Yuan, Constance, Stetler-Stevenson, Maryalice, Rassenti, Laura, Broome, H. Elizabeth, Kipps, Thomas J., Hauwel, Mathieu, Marinov, Iuri, Craig, Fiona E., Josep, Nomdedeu, Moreno, Carol, Stehlikova, Olga, Doubek, Michael, Pospisilova, Sarka, Kreuzer, Karl-Anton, Hallek, Michael, Hillmen, Peter, Montserrat, Emili and Ghia, Paolo
(2014).
A Complementary Role of High Throughput Sequencing and Multiparameter Cytometry for Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL):an European Research Initiative (ERIC) Study.
Blood, 124 (21).
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020
Roberts, Andrew W., Ma, Shuo, Kipps, Thomas J., Coutre, Steven E., Davids, Matthew S., Eichhorst, Barbara, Hallek, Michael, Byrd, John C., Humphrey, Kathryn, Zhou, Lang, Chyla, Brenda, Nielsen, Jacqueline, Potluri, Jalaja, Kim, Su Young, Verdugo, Maria, Stilgenbauer, Stephan, Wierda, William G. and Seymour, John F. (2019). Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables. Blood, 134 (2). S. 111 - 123. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Seymour, John F., Davids, Matthew S., Roberts, Andrew W., Hallek, Michael, Wierda, William G., Hillmen, Peter, Gerecitano, John F., Cerri, Elisa, Potluri, Jalaja, Kim, Su Young, Busman, Todd, Verdugo, Maria, Humerickhouse, Rod A., Best, Andrea, Desai, Monali and Stilgenbauer, Stephan (2016). Safety Profile of Venetoclax Monotherapy in Patients with Chronic Lymphocytic Leukemia. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Stilgenbauer, Stephan, Eichhorst, Barbara, Schetelig, Johannes, Coutre, Steven, Seymour, John F., Munir, Talha, Puvvada, Soham D., Wendtner, Clemens-Martin, Roberts, Andrew W., Jurczak, Wojciech ORCID: 0000-0003-1879-8084, Mulligan, Stephen P., Boettcher, Sebastian, Mobasher, Mehrdad, Zhu, Ming, Desai, Monali, Chyla, Brenda, Verdugo, Maria, Enschede, Sari Heitner, Cerri, Elisa, Humerickhouse, Rod, Gordon, Gary, Hallek, Michael and Wierda, William G.
(2016).
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study.
Lancet Oncol., 17 (6).
S. 768 - 779.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
Stilgenbauer, Stephan, Eichhorst, Barbara, Schetelig, Johannes, Hillmen, Peter, Seymour, John F., Coutre, Steven, Jurczak, Wojciech ORCID: 0000-0003-1879-8084, Mulligan, Stephen P., Schuh, Anna, Assouline, Sarit, Wendtner, Clemens-Martin, Roberts, Andrew W., Davids, Matthew S., Bloehdorn, Johannes, Munir, Talha, Boettcher, Sebastian, Zhou, Lang, Salem, Ahmed Hamed, Desai, Monali, Chyla, Brenda, Arzt, Jennifer, Kim, Su Young, Verdugo, Maria, Gordon, Gary, Hallek, Michael and Wierda, William G.
(2018).
Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial.
J. Clin. Oncol., 36 (19).
S. 1973 - 1984.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Wierda, William G., Kipps, Thomas J., Al-Sawaf, Othman, Chyla, Brenda, Biondo, Juliana M. L., Mun, Yong, Jiang, Yanwen and Seymour, John F. (2022). Utility of measurable residual disease for predicting treatment outcomes with BCR- and BCL2-Targeted therapies in patients with CLL. Leuk. Lymphoma, 63 (12). S. 2765 - 2785. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403